Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1998-09-15
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 534 14, 530300, A61K 5100, A61M 3614
Patent
active
058075380
ABSTRACT:
This invention relates to radiolabeled peptides and methods for producing such peptides. Specifically, the invention relates to technetium-99m (Tc-99m) labeled leukocyte-binding peptides, methods and kits for making such peptides, and methods for using such peptides to image sites of infection and inflammation in a mammalian body.
REFERENCES:
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 5277892 (1994-01-01), Rhodes
patent: 5376356 (1994-12-01), Morgan, Jr.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5506208 (1996-04-01), Eyal et al.
patent: 5552525 (1996-09-01), Dean
Buttram Scott
Dean Richard T.
Lees Robert S.
Diatide, Inc.
Hollinden Gary E.
Jones Dameron
McDaniels Patricia A.
Noonan Kevin E.
LandOfFree
Technetium-99m labeled peptides for imaging inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled peptides for imaging inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled peptides for imaging inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-84614